The Science Behind Ketamine Infusion Therapy: How It Works
Published: November 2024
For decades, the treatment of major depression and other mood disorders has relied primarily on selective serotonin reuptake inhibitors (SSRIs) and other conventional antidepressants. However, many patients find these medications ineffective or struggle with significant side effects. The emergence of ketamine infusion therapy represents a paradigm shift in psychiatric treatment, offering rapid relief for individuals who have not responded adequately to traditional approaches.
What is Ketamine?
Ketamine is a dissociative anesthetic that has been used in medical settings since the 1960s. Initially developed for anesthesia, researchers discovered that ketamine has profound effects on mood regulation at sub-anesthetic doses. Unlike traditional antidepressants that work through serotonin and norepinephrine pathways, ketamine acts as an antagonist at the N-methyl-D-aspartate (NMDA) receptor, a glutamate receptor in the brain.
How Does Ketamine Infusion Work?
When administered intravenously at therapeutic doses, ketamine triggers a cascade of neurobiological changes. By blocking NMDA receptors, it allows more glutamate activity through other pathways, which in turn activates downstream signaling cascades including the mammalian target of rapamycin (mTOR) pathway. This leads to increased production of brain-derived neurotrophic factor (BDNF), a protein essential for neuroplasticity and the formation of new neural connections.
This neurochemical mechanism is fundamentally different from how SSRIs work, which is why ketamine can be effective for treatment-resistant depression. The rapid activation of synaptic connections explains why patients often experience mood improvement within hours or days, rather than the weeks or months required for conventional antidepressants.
The Clinical Evidence
Numerous clinical trials have demonstrated the efficacy of ketamine infusion therapy for treatment-resistant depression. The FDA approved esketamine (Spravato), a nasal spray form of ketamine, in 2019 for treatment-resistant depression. However, intravenous ketamine infusions, which Save Minds specializes in, remain the gold standard for rapid symptom relief and provide superior bioavailability compared to other administration routes.
Research shows that 50-70% of patients with treatment-resistant depression experience significant symptom improvement following a course of ketamine infusions. Response rates are even higher for acute suicidal ideation, making ketamine therapy a life-saving intervention for individuals in crisis.
Beyond Depression: Treating Multiple Conditions
While ketamine's antidepressant properties are well-established, emerging evidence supports its use for various other psychiatric conditions. For PTSD patients, ketamine appears to reduce the emotional intensity of traumatic memories and facilitate exposure-based therapy. In anxiety disorders, patients report rapid anxiolytic effects during and after infusions. For OCD, ketamine's effects on glutamatergic neurotransmission may interrupt the obsessive-compulsive cycle.
At Save Minds, our consultant psychiatrists, led by Dr. Rajalingam Yadhunanthanan, carefully select appropriate patients and monitor their response throughout treatment. Each patient receives a personalized protocol based on their specific diagnosis, medical history, and treatment goals.
What to Expect During Treatment
A typical ketamine infusion session lasts approximately 40-60 minutes. Patients are monitored continuously by trained nursing staff while the medication is administered intravenously. Most people experience mild dissociative effects during the infusion, which typically resolve within 1-2 hours post-treatment. Common sensations include feeling detached from the body or surroundings, visual distortions, or an altered sense of time.
Treatment courses typically consist of 6-8 infusions over 2-4 weeks. Many patients notice improvement in mood, anxiety, or suicidal thoughts within the first few sessions. The dissociative experience itself, known as the "ketamine journey," appears to be therapeutically important, helping patients gain new perspectives on their difficulties.
Safety and Considerations
Ketamine is a safe medication when administered by trained medical professionals in a controlled clinical setting. However, it is not suitable for everyone. Individuals with uncontrolled hypertension, severe cardiac conditions, or active substance abuse may not be appropriate candidates. Pregnant women and those with a personal history of psychotic disorders require careful evaluation.
This is why the initial consultation at Save Minds is so important. Our experienced psychiatrists conduct a thorough assessment to ensure ketamine therapy is the right choice for each individual patient.
The Future of Psychiatric Treatment
Ketamine infusion therapy represents a major advance in psychiatric medicine. For patients who have suffered through multiple failed medication trials, endured years of debilitating symptoms, or struggled with acute suicidal crises, ketamine offers hope where conventional treatments have not. As research continues to expand our understanding of ketamine's mechanisms and optimal use, we can expect it to play an increasingly central role in modern psychiatric practice.
Save Minds remains at the forefront of this therapeutic revolution, providing London's most experienced consultant-led ketamine therapy program. If you or a loved one has struggled with treatment-resistant mental health conditions, we encourage you to reach out for a confidential consultation.